<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00015483</url>
  </required_header>
  <id_info>
    <org_study_id>5020-CP-001</org_study_id>
    <nct_id>NCT00015483</nct_id>
  </id_info>
  <brief_title>Hematotoxic Effects of Particulate Exposure</brief_title>
  <official_title>Hematotoxic Effects of Benzene and Doxorubicin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Environmental Health Sciences (NIEHS)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute of Environmental Health Sciences (NIEHS)</source>
  <brief_summary>
    <textblock>
      Hematotoxicity is caused by a number of agents such as a benzene by-product called&#xD;
      hydroquinone and the antitumor agent doxorubicin. This is a basic research study, conducted&#xD;
      using normal human donors, of mechanisms involved in hematotoxicity and of the protective&#xD;
      response of human hematopoietic progenitor cells to hematotoxic agents. Tumor necrosis factor&#xD;
      exposure protects these cells from a subsequent exposure to hematotoxic agents. The&#xD;
      alteration of gene expression in these cells caused by tumor necrosis factor is being&#xD;
      studied. Additionally, the tumor necrosis factor-induced biochemical pathways involved in&#xD;
      protection of human hematopoietic progenitor cells will be studied.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Cancer</condition>
  <eligibility>
    <criteria>
      <textblock>
        -  healthy&#xD;
&#xD;
          -  nonsmoking&#xD;
&#xD;
          -  no history of hematologic disorder&#xD;
&#xD;
          -  not pregnant&#xD;
&#xD;
          -  no medications which suppress hematopoiesis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>September 2006</verification_date>
  <study_first_submitted>April 20, 2001</study_first_submitted>
  <study_first_submitted_qc>April 20, 2001</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2001</study_first_posted>
  <last_update_submitted>September 1, 2006</last_update_submitted>
  <last_update_submitted_qc>September 1, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 4, 2006</last_update_posted>
  <keyword>Hematotoxicity</keyword>
  <keyword>Benzene</keyword>
  <keyword>Bone Marrow</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

